Free shipping on all orders over $ 500

 About 26 results found for searched term "LRRK2" (0.128 seconds)

Cat.No.  Name Target
M4949 LRRK2-IN-1 LRRK2
LRRK2-IN-1 is useful in treatment of Parkinson's disease.
LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM.
M49509 LRRK2-IN-8 LRRK2
LRRK2-IN-8 is a LRRK2 inhibitor.
M3649 GNE-7915 LRRK2
GNE-7915 is a highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor with IC50 and Ki of 9 nM and 1 nM, respectively.
M3795 GNE-9605 LRRK2
GNE-9605 is a highly potent, selective, and brain-penetrant LRRK2 inhibitor with IC50 of 19 nM.
M3929 PF-06447475 LRRK2
PF-06447475 is a highly potent, selective, brain penetrant LRRK2 inhibitor with IC0 of 3 nM/11 nM for Wt LRRK2/G2019S LRRK2 respectively.
M4831 GSK2578215A LRRK2
GSK2578215A is a potent and selective LRRK2 kinase inhibitor with IC50 of 8.9 nM and 10.9 nM for LRRK2 (G2019S) and LRRK2 (WT), respectively.
M5204 JH-II-127 LRRK2
JH-II-127 is a highly selective LRRK2 inhibitor with an IC50 = 6.5 nM.
M6649 CZC-25146 LRRK2
CZC 25146 is a potent and orally active LRRK2 inhibitor with IC50 values of 4.76 nM and 6.87 nM for wild-type LRRK2 and G2019S LRRK2, respectively. CZC-25146 inhibits PLK4, GAK, TNK1, CAMKK2 and PIP4K2C as well.
M8074 PF-06454589 Others
PF-06454589 is a potent and selective LRRK2 inhibitor.
M8313 CZC-25146 hydrochloride LRRK2
CZC-25146 is a potent selective and metabolically stable inhibitor of leucine-rich repeat kinase-2 (LRRK2) also known as dardarin or PARK8, a kinase with mutations linked to Parkinson’s disease.
M9510 JWG-071 ERK
JWG-071 is the first reported kinase-selective chemical probe for ERK5, inhibits ERK5 and LRRK2 with IC50 of 88 and 109 nM, respectively.
M10452 PFE-360 LRRK2
PF-06685360; PFE360
PFE-360, also known as PF-06685360, is a potent and selective, brain penetrated inhibitor of LRRK2 kinase.
M10595 MLi-2 LRRK2
MLi-2 is a highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity. MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).
M13572 GNE0877 LRRK2
GNE0877 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitor with an IC50 of 3 nM.
M13573 GNE-7915 tosylate LRRK2
GNE-7915 tosylate is a potent, selective and brain-penetrant inhibitor of LRRK2 with an IC50 of 9 nM.
M13574 HG-10-102-01 LRRK2
HG-10-102-01 is a potent and selective inhibitor of wild-type LRRK2(IC50=23.3 nM) and the G2019S mutant(IC50=3.2 nM).
M20140 WAY-333491 LRRK2
WAY-333491 is a LRRK2 kinase inhibitor.
M20669 CZC-54252 LRRK2
CZC-54252 is a potent and selective LRRK2 inhibitor with IC50s of 1.28 nM and 1.85 nM for human wild type LRRK2 and G2019S LRRK2, respectively.
M20811 XMD8-85 (ERK5-IN-1) ERK
XMD8-85 (ERK5-IN-1) is a selective and potent inhibitor of ERK5 and LRRK2 with IC50s of 0.162 μM and 0.339 μM, respectively.
M21292 EB-42486 LRRK2
EB-42486 is a novel potent and highly selective inhibitor of G2019S-LRRK2 (IC50 < 0.2 nM).
M21588 GSK2646264 Syk
GSK2646264 is a potent and selective splenic tyrosine kinase (Syk) inhibitor with a pIC50 value of 7.1. GSK2646264 also inhibited other kinases, with pIC50 values of 5.4, 5.4, 5.3, 5, 4.5, <4.6 and <4.3 for LCK, LRRK2, GSK3β, JAK2, VEGFR2, Aurora B and Aurora A, respectively. GSK2646264 penetrates into the epidermis and dermis of the skin.
M28571 PF-06455943  LRRK2
PF-06455943 is a leucine rich repeat kinase 2 (LRRK2) inhibitor with IC50 value of 3 nM. PF-06455943 also is a PET radioligand. PF-06455943 can be used for the research of ADME/neuro PK characterization and Parkinson disease (PD).
M28712 PF-06371900  LRRK2
PF-06371900 is a potent and highly selective leucine rich repeat kinase 2 (LRRK2) inhibitor.
M41387 JH-XII-03-02 PROTAC
JH-XII-03-02 is a potent and selective LRRK2 PROTAC degrader.
M50171 ARV-102 PROTAC
ARV-102 is a PROTAC degrader targeting LRRK2 for studies related to Parkinson's disease (PD).

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.